ascopubs.org

Efficacy and safety of first-line prolgolimab and nurulimab versus nivolumab and ipilimumab in advanced or metastatic melanoma: Indirect treatment comparison.

Treatment of patients with locally advanced and metastatic cutaneous squamous cell carcinoma (CSCC) with cemiplimab as first-line systemic therapy in Slovenia. Pembrolizumab monotherapy for melanoma ...
ascopubs.org

A meta-analysis of safety and efficacy of datopotamab deruxtecan and sacituzumab govitecan for second line treatment of metastatic non-small cell lung cancer (NSCLC).

First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors for patients with BRAFV600E-mutated metastatic non-small cell lung cancer: The FRONT-BRAF study. Pooled ...
Healio

Sacituzumab govitecan combo may be ‘new first-line standard of care’ in breast cancer subset

Please provide your email address to receive an email when new articles are posted on . Survival outcomes with the sacituzumab govitecan combination outweighed outcomes with chemotherapy combination ...
Healio

First-line combination should be ‘new standard’ in advanced lung cancer

Please provide your email address to receive an email when new articles are posted on . Amivantamab-vmjw plus lazertinib significantly improved OS for certain patients with advanced NSCLC compared ...
Cure Today

First-Line Enhertu Combo Gets Priority Review in HER2+ Metastatic Breast Cancer

Enhertu plus Perjeta received FDA priority review for first-line treatment of HER2-positive metastatic breast cancer, showing significant improvements in progression-free survival and response rates.